EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Excessive transcription-replication conflicts are a vulnerability of BRCA1 -mutant cancers

Parasvi S Patel iD, Arash Algouneh, Rehna Krishnan, John J Reynolds, Kevin C J Nixon, Jun Hao, Jihoon Lee, Yue Feng, Chehronai Fozil, Mia Stanic, Talya Yerlici, Peiran Su und 10 weitere

Nucleic Acids Research · 22.05.2023 · 51 (9) · 4341-4362

DOI: 10.1093/nar/gkad172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 17.03.2023. Verfasst von Parasvi S Patel und 21 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network, Toronto, OntarioM5G 1L7, Canada. Hauptthemen laut MEDLINE: BRCA1 Protein, DNA Replication, Hereditary Breast and Ovarian Cancer Syndrome, Mutation. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cancer Research UK, Terry Fox Foundation, Princess Margaret Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRCA1 mutations are associated with increased breast and ovarian cancer risk. BRCA1-mutant tumors are high-grade, recurrent, and often become resistant to standard therapies. Herein, we performed a targeted CRISPR-Cas9 screen and identified MEPCE, a methylphosphate capping enzyme, as a synthetic lethal interactor of BRCA1. Mechanistically, we demonstrate that depletion of MEPCE in a BRCA1-deficient setting led to dysregulated RNA polymerase II (RNAPII) promoter-proximal pausing, R-loop accumulation, and replication stress, contributing to transcription-replication collisions. These collisions compromise genomic integrity resulting in loss of viability of BRCA1-deficient cells. We also extend these findings to another RNAPII-regulating factor, PAF1. This study identifies a new class of synthetic lethal partners of BRCA1 that exploit the RNAPII pausing regulation and highlight the untapped potential of transcription-replication collision-inducing factors as unique potential therapeutic targets for treating cancers associated with BRCA1 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinDNA ReplicationHereditary Breast and Ovarian Cancer SyndromeMutationTranscription, GeneticHumansRNA Polymerase IIPromoter Regions, GeneticMethyltransferasesR-Loop StructuresCell DeathTranscription Factors

Substanzen

BRCA1 ProteinRNA Polymerase IIMethyltransferasesBRCA1 protein, humanPAF1 protein, humanTranscription FactorsMePCE protein, human

Autor:innen und Institutionen

  • Princess Margaret Cancer Centre, University Health Network, Toronto, OntarioM5G 1L7, Canada.
  • Department of Medical Biophysics, University of Toronto, OntarioM5G 1L7, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, OntarioM5S 1A8, Canada.
  • Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Department of Cell and Systems Biology, University of Toronto, OntarioM5S 3G5, Canada.
  • Terrence Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Parasvi S Patel, Fraser Soares, Gary D Baider, Razqallah Hakem

Förderung

  • Cancer Research UK
  • Terry Fox Foundation
  • Princess Margaret Cancer Foundation
  • Department of Medical Biophysics, University of Toronto
  • Government of Ontario
  • Canada Graduate Scholarships
  • Ontario Graduate Scholarship
  • Department of Laboratory Medicine and Pathobiology, University of Toronto

Zitieren

APA

Patel, P. S., Algouneh, A., Krishnan, R., Reynolds, J. J., Nixon, K. C. J., Hao, J., Lee, J., Feng, Y., Fozil, C., Stanic, M., Yerlici, T., Su, P., Soares, F., Liedtke, E., Prive, G., Baider, G. D., Pujana, M. A., Mekhail, K., He, H. H., …, & Hakem, R. (2023). Excessive transcription-replication conflicts are a vulnerability of BRCA1 -mutant cancers. Nucleic Acids Research, 51(9), 4341-4362. https://doi.org/10.1093/nar/gkad172

Vancouver

Patel PS, Algouneh A, Krishnan R, Reynolds JJ, Nixon KCJ, Hao J, et al. Excessive transcription-replication conflicts are a vulnerability of BRCA1 -mutant cancers. Nucleic Acids Research. 2023;51(9):4341-4362. doi:10.1093/nar/gkad172

BibTeX
@article{Patel2023,
  author = {Patel, Parasvi S and Algouneh, Arash and Krishnan, Rehna and Reynolds, John J and Nixon, Kevin C J and Hao, Jun and Lee, Jihoon and Feng, Yue and Fozil, Chehronai and Stanic, Mia and Yerlici, Talya and Su, Peiran and Soares, Fraser and Liedtke, Elisabeth and Prive, Gil and Baider, Gary D and Pujana, Miquel Angel and Mekhail, Karim and He, Housheng Hansen and Hakem, Anne and Stewart, Grant S and Hakem, Razqallah},
  title = {Excessive transcription-replication conflicts are a vulnerability of BRCA1 -mutant cancers},
  journal = {Nucleic Acids Research},
  year = {2023},
  volume = {51},
  number = {9},
  pages = {4341--4362},
  doi = {10.1093/nar/gkad172}
}
Kostenlos starten →